Raising a seed round in medtech.
What seed investors expect from a medtech company, who writes checks at this stage, the terms you will see and the slides they read first.
Medtech
Medtech investors fund a device through three gates: a regulatory pathway, clinical evidence and a way to get paid. Your FDA route sets how much capital you need and how long it takes.
What seed investors expect in medtech
Seed in medtech funds design freeze and early testing. Show each of these on a slide of its own.
A pathway you have tested
- A chosen FDA route with reasons, not guesses
- A pre-submission meeting planned or held
- The testing the regulator will likely expect
Early evidence
- Bench, animal or cadaver results
- A first-in-human study planned, if needed
- A quality system started early, not bolted on later
A way to get paid
- Whether an existing billing code covers the procedure
- Who buys it in a hospital and how they decide
- A price that works for buyer and for your margin
How the round comes together
Investor types, not names. Read each guide, then match inside your account.
- 1 · A specialist fund leads
- 2 · Angels and grants fill
- 3 · Strategics watch
Pre-seed & seed funds
Often leads
Medtech seed funds lead most device seed rounds.
Angels
Often follows
Physicians and device executives fill out the round.
Grants & non-dilutive
Sometimes
Later-phase grants fund testing alongside equity.
Angel groups
Sometimes
Physician-heavy groups syndicate into device rounds.
Corporate VCs
Now and then
Device makers sometimes invest early to watch a technology.
SAFE or priced round?
Smaller medtech seed rounds use SAFEs. Larger rounds with a specialist lead are often priced, sometimes released in tranches tied to testing or regulatory milestones. Keep milestones within your control.
The slides investors read first
Device
Design status and what has been tested.
Regulatory
FDA route, pre-sub feedback and timing.
Evidence
Bench and early clinical results.
Reimbursement
Codes, buyers and the price you will charge.
The ask
Amount, instrument, and the milestone it buys.
Questions founders ask
What is a pre-submission meeting?
A voluntary meeting where you ask the FDA for feedback on your planned pathway and testing before you file. Investors value it because it reduces regulatory guesswork.
Do medtech seed investors expect revenue?
Rarely. Most devices cannot be sold before clearance or approval. Investors judge progress on design, testing and regulatory milestones instead.
Sources
Sources: FDA guidance on device classification, 510(k), De Novo and PMA pathways; CMS coverage and coding resources; investors' published criteria. Editorial content, reviewed quarterly. Not financial, legal or medical advice.
Other stages
Related sectors
Who funds this round
Learn the terms
Run the numbers
Raise in your city
Inside Unicorn Factory
Free account
Investor matching is coming to your free account. Create it now and we will match your round the day it opens. Until then, get an honest read on your deck.